These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24447133)

  • 41. Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failure.
    Harskamp RE; Beijk MA; Damman P; Kuijt WJ; Woudstra P; Grundeken MJ; Kloek JJ; Tijssen JG; de Mol BA; de Winter RJ
    J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):438-45. PubMed ID: 22828774
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coronary artery bypass grafting versus drug-eluting stent implantation for left main coronary artery disease (from a two-center registry).
    Kang SH; Park KH; Choi DJ; Park KW; Chung WY; Lim C; Kim KB; Kim HS
    Am J Cardiol; 2010 Feb; 105(3):343-51. PubMed ID: 20102946
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical outcomes of treatment by percutaneous coronary intervention versus coronary artery bypass graft surgery in patients with chronic kidney disease undergoing index revascularization in Ontario.
    Chan W; Ivanov J; Ko D; Fremes S; Rao V; Jolly S; Cantor WJ; Lavi S; Overgaard CB; Ruel M; Tu JV; Džavík V
    Circ Cardiovasc Interv; 2015 Jan; 8(1):. PubMed ID: 25582144
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery disease.
    Mack MJ; Head SJ; Holmes DR; Ståhle E; Feldman TE; Colombo A; Morice MC; Unger F; Erglis A; Stoler R; Dawkins KD; Serruys PW; Mohr FW; Kappetein AP
    JACC Cardiovasc Interv; 2013 Apr; 6(4):344-54. PubMed ID: 23523456
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of drug eluting stent implantation with coronary artery bypass surgery in the treatment of patients with chronic total occlusion and multiple vessel disease.
    Liu W; Ma CS; Kang JP; Du X; Chen F; Zhou YJ; Lü SZ; Huang FJ; Gu CX; Zhu XL
    Chin Med J (Engl); 2011 Apr; 124(8):1169-74. PubMed ID: 21542990
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Prognostic analysis of drug-eluting stent implantation and coronary artery bypass grafting in patients with unprotected left main coronary artery disease complicated with chronic renal failure].
    Pan Y; Mu Y; Zhang Y; He J; Qiu Q
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Oct; 32(10):1203-1207. PubMed ID: 33198864
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease.
    Hannan EL; Wu C; Walford G; Culliford AT; Gold JP; Smith CR; Higgins RS; Carlson RE; Jones RH
    N Engl J Med; 2008 Jan; 358(4):331-41. PubMed ID: 18216353
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries.
    Head SJ; Holmes DR; Mack MJ; Serruys PW; Mohr FW; Morice MC; Colombo A; Kappetein AP;
    JACC Cardiovasc Interv; 2012 Jun; 5(6):618-25. PubMed ID: 22721656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Five-year follow-up of drug-eluting stents implantation vs minimally invasive direct coronary artery bypass for left anterior descending artery disease: a propensity score analysis.
    Etienne PY; D'hoore W; Papadatos S; Mairy Y; El Khoury G; Noirhomme P; Hanet C; Glineur D
    Eur J Cardiothorac Surg; 2013 Nov; 44(5):884-90. PubMed ID: 23492989
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug-eluting stents compared with bilateral internal thoracic artery grafts for diabetic patients.
    Moshkovitz Y; Mohr R; Medalion B; Hyam E; Herz I; Deitch I; Uretzky G; Pevni D
    Ann Thorac Surg; 2012 Nov; 94(5):1455-62. PubMed ID: 22748647
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Percutaneous coronary intervention in patients with previous coronary artery bypass grafting (from the j-Cypher Registry).
    Yamaji K; Kimura T; Morimoto T; Nakagawa Y; Inoue K; Nobuyoshi M; Mitsudo K;
    Am J Cardiol; 2013 Oct; 112(8):1110-9. PubMed ID: 23827399
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug-eluting stents versus coronary artery bypass grafting in diabetic patients with multi-vessel disease: a meta-analysis.
    Lim JY; Deo SV; Kim WS; Altarabsheh SE; Erwin PJ; Park SJ
    Heart Lung Circ; 2014 Aug; 23(8):717-25. PubMed ID: 24704466
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data.
    Head SJ; Mack MJ; Holmes DR; Mohr FW; Morice MC; Serruys PW; Kappetein AP
    Eur J Cardiothorac Surg; 2012 Mar; 41(3):535-41. PubMed ID: 22219412
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of chronic kidney disease on long-term clinical outcomes after percutaneous coronary intervention with drug-eluting or bare-metal stents.
    Kersting S; Grumann T; Hummel J; Hauschke D; Bode C; Hehrlein C
    Crit Pathw Cardiol; 2012 Sep; 11(3):152-9. PubMed ID: 22825536
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Meta-analysis of clinical studies comparing coronary artery bypass grafting with percutaneous coronary intervention in patients with end-stage renal disease.
    Zheng H; Xue S; Lian F; Huang RT; Hu ZL; Wang YY
    Eur J Cardiothorac Surg; 2013 Mar; 43(3):459-67. PubMed ID: 22778175
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Coronary artery bypass grafting vs percutaneous coronary intervention in a 'real-world' setting: a comparative effectiveness study based on propensity score-matched cohorts.
    Fortuna D; Nicolini F; Guastaroba P; De Palma R; Di Bartolomeo S; Saia F; Pacini D; Grilli R; ;
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):e16-24. PubMed ID: 23628951
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bypass versus drug-eluting stents at three years in SYNTAX patients with diabetes mellitus or metabolic syndrome.
    Mack MJ; Banning AP; Serruys PW; Morice MC; Taeymans Y; Van Nooten G; Possati G; Crea F; Hood KL; Leadley K; Dawkins KD; Kappetein AP
    Ann Thorac Surg; 2011 Dec; 92(6):2140-6. PubMed ID: 21967819
    [TBL] [Abstract][Full Text] [Related]  

  • 58. First- versus second-generation drug-eluting stents for the treatment of coronary bifurcations.
    Costopoulos C; Latib A; Ferrarello S; Naganuma T; Sticchi A; Filippo F; Giannini F; Basavarajaiah S; Kawaguchi M; Naim C; Candreva A; Carlino M; Chieffo A; Montorfano M; Colombo A
    Cardiovasc Revasc Med; 2013; 14(6):311-5. PubMed ID: 24157311
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early beneficial effects of drug-eluting stents in vein grafts wane during long term follow-up: a case-control study.
    Pasceri V; Tarsia G; Niccoli G; Viceconte N; Porto I; Leone AM; Trani C; Speciale G; Lisanti P
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1112-7. PubMed ID: 22422701
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative long-term efficacy and safety of drug-eluting stent versus coronary artery bypass grafting in ostial left main coronary artery disease: analysis of the MAIN-COMPARE registry.
    Lee SW; Kim SH; Kim SO; Han S; Kim YH; Park DW; Kang SJ; Lee CW; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2012 Aug; 80(2):206-12. PubMed ID: 22234884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.